CureVac NV

CVAC

NASDAQ. Currency in USD

7.88 -0.16 ( -1.99% )

Real time prices: September 30

Market Cap.
1.48B
Beta (5Y monthly)
3.01
Price/Earnings
-
EPS (TTM)
-1.63
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
246,436
1y Target Est.
51.79
Day's Range
7.88
-
8.33
52 Week's Range
6.99
-
50.09

Historical Summary

Performance
EPS growth
Share Buybacks

About CureVac NV

Sector
Healthcare
Industry
Biotechnology
Website
https://www.curevac.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
186.83M
Employees
764
Address
Friedrich-Miescher-Strasse 15, Tübingen, Germany, 72076
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 clinical trial against influenza, as well as vaccine for lassa fever, yellow fever, respiratiory syncytial virus, rotavirus, malaria, and universal influenza. The company also develops RNA-based cancer immunotherapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck. The company was founded in 2000 and is headquartered in Tübingen, Germany.

Latest news

Bet on These 4 Biotech Stocks With Bright Prospects
Bet on These 4 Biotech Stocks With Bright Prospects

New drug approvals and pipeline development should maintain momentum for the Zacks Biomedical and Genetics...
By Zacks Investment Research - 4 days ago

Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday

Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) shares jumped 167.7% to close at $2.20 on Thursday...
By Benzinga - 1 week ago

Here's Why CureVac N.V. (CVAC) is Poised for a Turnaround After Losing 20.9% in 4 Weeks
Here's Why CureVac N.V. (CVAC) is Poised for a Turnaround After Losing 20.9% in 4 Weeks

CureVac N.V. (CVAC) has become technically an oversold stock now, which implies exhaustion of the...
By Zacks Investment Research - 4 weeks ago

Apple, Amazon, HP And Other Big Losers From Friday
Apple, Amazon, HP And Other Big Losers From Friday

U.S. stocks closed sharply lower with the Dow Jones tumbling more than 1,000 points on...
By Benzinga - 4 weeks ago

Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday
Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday

Gainers Micro Focus International plc (NYSE: MFGP) shares surged 92% to close at $6.01 on...
By Benzinga - 5 weeks ago

Wall Street Analysts Predict a 96% Upside in CureVac N.V. (CVAC): Here's What You Should Know
Wall Street Analysts Predict a 96% Upside in CureVac N.V. (CVAC): Here's What You Should Know

The mean of analysts' price targets for CureVac N.V. (CVAC) points to a 96.4% upside...
By Zacks Investment Research - 11 weeks ago

COVID hospitalizations dip for first time since mid-April, but daily deaths reach 2 1/2-month high
COVID hospitalizations dip for first time since mid-April, but daily deaths reach 2 1/2-month high

While the daily average of new COVID-19 cases have settled back into a low-100K range...
By MarketWatch - 12 weeks ago

Wall Street Analysts See a 53% Upside in CureVac N.V. (CVAC): Can the Stock Really Move This High?
Wall Street Analysts See a 53% Upside in CureVac N.V. (CVAC): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of...
By Zacks Investment Research - 17 weeks ago